Pharmaceutical Research and Manufacturers of America (PhRMA)

Registered Principal Details

Business Or Interest:
Research and manufacturing pharmaceuticals organizations

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries

CEO Name:
John Castellani
Vice President, State Advocacy

Contact
KM
Kenneth McKay
950 F Street NW, Suite 300
Washington, DC 20004
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Thomas E Moore Exclusive Duties N/A Authorized On 12/28/2016 Withdrawn On N/A
Steven M Foti Exclusive Duties N/A Authorized On 12/28/2016 Withdrawn On N/A
Saiza Elayda Exclusive Duties N/A Authorized On 2/20/2018 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 69
Assembly Bill 69
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.

Bill Text and History

Other
Notification Date
2/23/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
PhRMA is neutral on the bill provided participation by manufacturers remains optional and voluntary and the bill's liability provisions remain intact
Assembly Bill 335
Assembly Bill 335
Relating to: fentanyl analogs and providing a criminal penalty.

Bill Text and History

2017 Wisconsin Act 60

None
Notification Date
6/28/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 620
Assembly Bill 620
Relating to: prescription drug cost reporting by manufacturers and providing a penalty. (FE)

Bill Text and History

Against
Notification Date
1/15/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 800
Assembly Bill 800
Relating to: disclosures of prescription drug costs under health insurance policies and plans.

Bill Text and History

For
Notification Date
1/15/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 531
Senate Bill 531
Relating to: prescription drug cost reporting by manufacturers and providing a penalty. (FE)

Bill Text and History

Against
Notification Date
1/15/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 669
Senate Bill 669
Relating to: disclosures of prescription drug costs under health insurance policies and plans.

Bill Text and History

For
Notification Date
1/15/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Health Carrier Prescription Drug Benefit Management Model Act
Development, drafting or introduction of a proposal relating to
Health Carrier Prescription Drug Benefit Management Model Act

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

SeniorCare
Development, drafting or introduction of a proposal relating to
SeniorCare

Action Intended To Affect
Both Legislative matter and rule

Notification Date
5/22/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Access to prescription drugs
Development, drafting or introduction of a proposal relating to
Access to prescription drugs

Action Intended To Affect
Legislative matter

Notification Date
1/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Medicaid budget
Development, drafting or introduction of a proposal relating to
Medicaid budget

Action Intended To Affect
Legislative matter

Notification Date
1/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB 1201 re: synthetic opiates
Development, drafting or introduction of a proposal relating to
LRB 1201 re: synthetic opiates

Action Intended To Affect
Legislative matter

Notification Date
1/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$48,777.35
2017
July - December
$51,120.00
2018
January - June
$57,470.30
2018
July - December
$28,360.12
Total $185,727.77
Total Hours Communicating 2017
January - June
21.00
2017
July - December
15.00
2018
January - June
18.00
2018
July - December
6.50
Total 60.50
Total Hours Other 2017
January - June
47.50
2017
July - December
87.50
2018
January - June
37.30
2018
July - December
37.35
Total 209.65

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
25 %
2018
January - June
2018
July - December
Total 10 %
Relating to: fentanyl analogs and providing a criminal penalty.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
50 %
2018
January - June
2018
July - December
Total 19 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
25 %
2017
July - December
2018
January - June
2018
July - December
Total 6 %
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
10 %
2018
July - December
Total 2 %
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
20 %
2018
July - December
35 %
Total 10 %
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
20 %
2018
July - December
Total 4 %

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
65 %
2017
July - December
20 %
2018
January - June
40 %
2018
July - December
15 %
Total 35 %

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
10 %
2017
July - December
5 %
2018
January - June
10 %
2018
July - December
50 %
Total 15 %

Filed Statements of Lobbying Activity and Expenditures